Atlas Trials

Safety and Tolerability of HSC835 in Patients With Hematological Malignancies

Clinical trial NCT01474681 · COMPLETED

Trial details

NCT number
NCT01474681
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Acute Myelocytic LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous LeukemiaMyelodysplastic SyndromeChronic Lymphocytic LeukemiaMarginal Zone LymphomaFollicular LymphomasLarge-cell LymphomaLymphoblastic LymphomaBurkitt's LymphomaHigh Grade LymphomasMantle-cell Lymphoma
Start date
2012-01-09
Primary completion
2016-10-03
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.